1-3 of 3
Yanyan Li, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Gili Kenet, MD, Andres Brainsky, MD, Jerry S. Powell, MD, Yanyan Li, PhD, Wilfried Seifert, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2370.
https://doi.org/10.1182/blood.V130.Suppl_1.2370.2370
Published: 2017
Journal Articles

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Ingrid Pabinger, MD, Elena Santagostino, Andres Brainsky, MD, Jerry S. Powell, MD, Yanyan Li, PhD, Wilfried Seifert, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3690.
https://doi.org/10.1182/blood.V130.Suppl_1.3690.3690
Published: 2017
Journal Articles

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B

Elena Santagostino, MD PhD, Christine Voigt, PhD, Denise Wolko, Grace Cole, Yanyan Li, PhD, Iris C. Jacobs, MD
Journal: Blood
Blood (2015) 126 (23): 548.
https://doi.org/10.1182/blood.V126.23.548.548
Published: 2015